HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Fosun Tourism (1992.HK) Privatization - The Cancellation Price Is Not Good Enough

CPMC Holdings (906.HK) Update - The Critical Moment Has Arrived

CPMC Holdings (906.HK) Privatization - Some New Information Worth the Attention

CPMC Holdings (906.HK) Privatization Update - Will ORG Withdraw Midway?

CPMC Holdings (906.HK) Update - These Are the Reasons Why We Find This Deal "Tricky"

Greatview Aseptic Packaging (468.HK) Update - Some New Information Worth the Attention

Event-Driven

<ul>
<li>If ORG cannot obtain the SAFE approval by the end of December, this indicates something is wrong in the process. Then the success rate of this transaction is greatly reduced.</li>
<li>Acquiring CPMC is in line with Baosteel's strategic goals and CPMC is important to Baosteel.So, the possibility of state-owned capital to agree to withdraw completely from CPMC is not high.</li>
<li>It’s unclear whether Zhang Wei will continue to side with ORG, or whether he still want to exit. This actually depends on the renegotiations between Baosteel/China Foods/COFCO and Zhang Wei.</li>
</ul>


If ORG cannot obtain the SAFE approval by the end of December, this indicates something is wrong in the process. Then the success rate of this transaction is greatly reduced.
Acquiring CPMC is in line with Baosteel's strategic goals and CPMC is important to Baosteel.So, the possibility of state-owned capital to agree to withdraw completely from CPMC is not high.
It’s unclear whether Zhang Wei will continue to side with ORG, or whether he still want to exit. This actually depends on the renegotiations between Baosteel/China Foods/COFCO and Zhang Wei.


Shanghai Baosteel Packaging-A (601968 CH)

CPMC Holdings (906.HK) Update - It's Time to Prepare for Different Scenarios